Dr Omid Yeganeh, Islamic Azad University, Iran
Dr. Omid Yeganeh is a microbiologist with a Ph.D. in Microbiology from the Islamic Azad University, Tehran, Iran. He also holds an M.Sc. in Microbiology and a B.Sc. in Cellular and Molecular Biology. As a researcher at the Monoclonal Antibody Research Center, Avicenna Research Institute, he specializes in producing monoclonal antibodies against various molecules, including PSA, prolactin, ferritin, and sperm surface antigens. Dr. Yeganeh serves as a technical editor and associate editor for several journals, contributing to the advancement of microbiological research. His work has significantly impacted the field of immunology and antibody development. 🔬🧬💉
Publication profile
google scholar
Education
Dr. Omid Yeganeh holds an impressive academic background, earning a Ph.D. in Microbiology from the Department of Microbiology at the Islamic Azad University, Tehran, Iran. His M.Sc. in Microbiology and B.Sc. in Cellular and Molecular Biology with a focus on Microbiology further enhance his foundational knowledge in the field. As a member of the Monoclonal Antibody Research Center at the Avicenna Research Institute, he is well-versed in cutting-edge research methodologies.
Research Experience
Dr. Yeganeh’s extensive experience as a researcher at the Monoclonal Antibody Research Center showcases his commitment to advancing the field of microbiology and immunology. His role as a technical editor and associate editor for scientific journals highlights his expertise and active participation in academic discourse. His hands-on research experience equips him with a practical understanding of the latest methodologies in microbiology.
Research Activities
His work focuses on the production of monoclonal antibodies against various clinically significant molecules, including PSA, prolactin, and sperm surface antigens. He has successfully produced monoclonal antibodies against over 100 different peptides, showcasing his technical expertise in hybridoma techniques and cell culture. This innovative research has the potential to contribute significantly to diagnostic and therapeutic applications in medicine.
Congress Participation
Dr. Yeganeh actively participates in international congresses, such as the 15th Virtual International Congress of Immunology & Allergy and the ICIA 2023, where he presents his research findings. His engagement in these forums not only broadens his professional network but also enhances the visibility of his research contributions on a global scale.
Research focus
Dr. Omid Yeganeh is a prominent researcher with a focus on medical biotechnology, particularly in immunology and microbiology. His work includes the production and characterization of monoclonal antibodies against various human proteins and pathogens, highlighting his expertise in antibody development for diagnostic and therapeutic applications. He has also investigated infectious diseases, including the emergence of antibiotic-resistant bacteria, contributing to the understanding of microbial drug resistance. His research significantly impacts both clinical diagnostics and therapeutic strategies. 🧬🔬📊
Publication top notes
Intra-and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction …
The Challenge of Global Emergence of Novel Colistin-Resistant Escherichia coli ST131
Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta‐specific 1
A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad …
Production and characterization of a murine monoclonal antibody against human ferritin
Skull base aneurysmal bone cyst presented with foramen jugular syndrome and multi-osseous involvement
Fibro-osseous lesions of the skull base in the pediatric population
Production and characterization of monoclonal antibodies against human prostate specific antigen
Conclusion
Dr. Omid Yeganeh’s academic credentials, research experience, and extensive publication record make him a highly suitable candidate for the Best Researcher Award. His innovative research in monoclonal antibody production and his commitment to advancing scientific knowledge in microbiology not only demonstrate his capabilities as a researcher but also indicate his potential for future contributions to the field.